US Corporate Board Director Changes SEC Filings — June 22, 2026

USA Board Room Changes

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

Today's digest of 50 USA board room changes reveals a significant uptick in CEO and C-suite successions, with a clear focus on internal promotions alongside a few notable departures linked to operational performance.

The period-over-period data highlights divergent strategic outcomes: while companies like Domino's Pizza and PagerDuty leverage strong operational momentum for leadership transitions, Primoris Services exemplifies a direct link between board-level changes and severe financial underperformance, slashing its 2026 guidance by nearly 70%. A key theme is the increasing use of shareholder meetings as a barometer of investor sentiment, with director elections at ORIC Pharmaceuticals, MARA Holdings, and BridgeBio Oncology Therapeutics revealing notable opposition (19-41% withheld votes), signaling governance concerns or strategic disagreements. Insider activity is muted in the filings, but capital allocation moves, such as Primoris's $50M buyback and Domino's significant retail sales growth, provide context for new management's mandate. The synthesis underscores that while many changes are routine successions, several carry high materiality due to their linkage to strategic pivots, severe guidance revisions, or shareholder revolts.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from June 18, 2026.

Investment Signals (12)

  • Domino's Pizza (BULLISH)

    CEO succession plan announced with COO Joe Jordan taking over Oct 1, 2026. Weiner's tenure saw net store growth of 3,200+, $3B in global retail sales growth, and a ~30% increase in operating income. This is a meticulously planned handoff with a strong track record, signaling continuity and confidence.

  • COO departure and severe guidance revision (Adj. EBITDA cut from $480-500M to $275-325M) due to $200M+ in renewables cost overruns. New CEO is absorbing COO duties. The board is in crisis management mode; a clear BULLISH signal for the long-term thesis but a BEARISH short-term catalyst as Q2 2026 results will reflect the full impact.

  • PagerDuty (BULLISH)

    Appointment of Eric Prengel as CFO from Elastic. PagerDuty serves ~2/3 of the Fortune 100. This is a strong hire with public company and high-growth SaaS experience (JPMorgan, Deutsche Bank), signaling a focus on scaling profitability and investor relations.

  • Revium Rx (BEARISH)

    Director/COO Inna Martin resigned due to 'differences with the Company' (7/10 materiality). Signaled in her separation agreement, which extends the exercise period for 2.44M shares. This is a high-sentiment conflict, likely pointing to operational or strategic disagreements, a significant red flag for a micro-cap.

  • Annual meeting results show significant founder/retail vs. institutional friction. Director Vicki Mealer-Burke received a 40.8% vote-withheld tally, a strong signal of shareholder dissatisfaction with board oversight or compensation. The 18 million share equity plan increase also passed, which is dilutive.

  • Co-founder and President Ichiro Aoki resigns effective June 29, transitioning to a technical advisor role. Thomas Schiller (former CFO) joins the board. This suggests a strategic pivot away from founder-led engineering towards deeper financial and strategic oversight, particularly as they target robotics/adjacent AI markets.

  • Arvinas (BEARISH)

    CMO Noah Berkowitz departs (effective July 3, 2026) to 'pursue other opportunities'. The departure of a key clinical leader is a material loss for a biotech, especially given the company is in a competitive space. The search is underway, creating a period of uncertainty in R&D.

  • IAC Inc. (BULLISH)

    Voting agreement caps Barry Diller's voting power to 48.5%, restricting his ability to act via written consent. This is a significant governance move that de-risks the stock for minority shareholders, making a coercive take-private or drastic shareholder-unfriendly moves less likely.

  • Internal promotions for COO (David Morris, ex-CFO) and CFO (Will Mudd, ex-SVP). This signals a well-executed talent development pipeline and operational stability, reducing execution risk around the leadership changes. Gross margin trends would be key to watch.

  • Appointed Dr. Dave Young (ex-Lockheed Martin, managed a $7B business) as EVP and COO. This is a significant upgrade in operational depth from a major defense prime, signaling CACI is positioning for large program wins and stronger execution within the defense tech sector.

  • New CEO agreement includes performance-based RSUs with stock price hurdles at $105, $120, and $135 per share, up from current levels. This is an extremely ambitious, bull-case alignment of management with long-term value creation, but also a risk of significant dilution if they don't perform.

  • Director, Treasurer, and Secretary resignations followed by new appointments, with the old director retained in an advisory capacity. This appears to be a specific governance housecleaning, possibly cued by activist pressure or a strategic pivot by the company. [NEUTRAL/MIXED]

Risk Flags (12)

  • Full-year 2026 net income guidance slashed nearly 70% from $223-234M to $71-101M due to six renewables project failures. This is a fundamental business model risk where project execution is failing. Q2 2026 results will be the next catalyst.

  • Vicki Mealer-Burke had 40.8% of votes withheld. Combined with a 18M share dilution from the new equity plan, this points to deep shareholder governance concerns, potentially over compensation or strategic direction.

  • The amended 2020 Equity Incentive Plan faced significant opposition (27.3M against vs 61.2M for). The removal of the annual evergreen limit creates unlimited dilution risk over time, a red flag for shareholders.

  • COO/President Inna Martin resigns due to 'differences' with the company. The 2.44M share option extension is a major retention/severance gesture, but the fundamental conflict points to serious internal strife at this micro-cap biotech.

  • Director Frank P. McCormick received 19.4% 'withheld' votes at the AGM. This is a strong rebuke for a key scientific founder, suggesting shareholder unease with the board's composition or strategy.

  • 20.6% of votes were AGAINST the plan amendment to increase shares by 4.9M. This level of opposition on an equity plan is a strong signal of shareholder discontent regarding dilution.

  • CFO Matt Bilunas (20-year veteran) is stepping down July 31, 2026. Only an external search has been engaged. This creates an uncertain leadership vacuum at a critical inflection point for a legacy retailer.

  • The disclosed CEO pay ratio of 36.9:1 ($1.8M CEO vs $49k median) could be a flashpoint for ESG/activist scrutiny, especially given a 10% SERP amendment for a single executive.

  • Authorized shares increased to 600 million from an undisclosed lower amount. While passed by shareholders, this 10x+ expansion creates massive potential dilution, a classic

  • [HIGH RISK]

    suppression tactic for a pre-revenue biotech.

  • Director Lauren M. Tyler was appointed, but she is an outsider with 30+ years of experience. The filing does not disclose vote counts, but her appointment being a given suggests an uncontested slate for a large cap, masking potential under-the-radar dissent.

  • The agreement includes 2x salary + 2x target bonus severance without cause, and 24 months non-compete. This is a 'golden parachute' that could entrench management even if performance falters.

Opportunities (10)

  • Domino's Pizza / CEO Succession Coup (OPPORTUNITY)

    The planned succession is a multi-year process with a strong track record. The incoming CEO (Joe Jordan) is coming from a role (COO) that directly drives operational performance. The outgoing CEO's strong P&L performance over 7.5 years provides a deep bench of strategic continuity. Opportunity to buy on any dip if the market misprices transition risk.

  • The severe stock correction on the guidance cut creates a potential deep value entry point. The core business (Energy segment) secured $2B in new awards in Q2 2026 alone. If the renewables cost overruns are truly isolated and the new CEO proves effective, the current valuation (at trough earnings) is deeply discounted.

  • The appointment of Eric Prengel from Elastic (a market leader) and a top-tier investment banking background signals a focus on improving operational margins and a potential M&A or capital strategy pivot. The stock is unloved in the SaaS space; a new CFO can be a strong positive narrative catalyst.

  • The voting agreement that caps Barry Diller's influence is a major governance upgrade. This removes the 'Diller overhang' that often scares away institutional investors. The stock could re-rate higher as the 'governance discount' narrows.

  • While negative, the departure of a CMO opens a door for a fresh perspective. If the company hires a CMO with a successful track record in their specific targeted therapy area, it could de-risk the pipeline. The share price will likely dip, creating a better entry point for the long-term bull thesis.

  • A CFO search with external candidates could bring in fresh financial rigor and potentially a more aggressive cost-cutting or capital return strategy (buybacks, dividends). Given the stock's valuation, a credible new CFO narrative could be a strong catalyst.

  • Elected Shoshana Vernick, co-founder of a PE firm focused on education and knowledge services. This brings a highly strategic, deal-oriented perspective to the board, potentially opening doors to M&A or spin-off opportunities.

  • The 27.3M votes against the equity plan could be a precursor to activist engagement. If directors are forced to change governance, it could unlock value. This is a high-risk/high-return event to watch.

  • Appointed Douglas Britt, a tech exec who recently led the sale of a business to a larger entity (Eaton). His expertise could be invaluable if the board is considering strategic portfolio rationalization (spin-offs, divestitures).

  • The strong vote against a board member (40.8%) is a clear signal from shareholders. This could be the trigger for a governance overhaul that leads to better capital allocation (e.g., selling Bitcoin hoard, share repurchase) and a re-rating.

Sector Themes (6)

  • Shareholder Activism Proxy Season

    Multiple companies (MARA Holdings, Oric, BridgeBio, EyePoint, and OneMain) showed significant opposition on director elections or equity plan proposals. This indicates a heightened level of shareholder scrutiny across the board, not just in a single sector. Investors should assess their holdings for similar governance risks.

  • Internal Succession vs. External Hires for CFO Roles

    The pattern shows a clear bifurcation. Companies with strong operational momentum (Guardian Pharmacy, PagerDuty) favor internal CFO promotions (stability / low execution risk). Conversely, companies facing disruption or need for strategic pivot (Best Buy, Five9, CACI) are using external searches. This is a leading indicator of management's risk appetite.

  • CEO-to-Chairman Titles as a Norm

    Multiple filings (A.O. Smith, Domino's, Panamera Holdings) show the CEO also assuming the Chairman role. This concentration of power typically signals a stronger mandate but also increases governance risk. It's a notable trend in mid-to-large caps that investors often underappreciate until a crisis hits.

  • Guidance Runway as Leadership Barometer

    The Primoris guidance cut is the extreme example, but it highlights the critical role of external financial guidance in assessing board change quality. New leadership at companies with bad guidance (Primoris) get a 'reset' narrative. New leadership at companies with rising guidance (Domino's, PagerDuty) inherit a 'sell high' narrative. This is the single biggest differentiator for investment outcomes.

  • Biotech Board Turnover Signaling Scientific Pivot

    Multiple biotechs (Arvinas, BridgeBio, EyePoint, Dyne) saw director changes. This is a sector where board composition is critical for credibility. The mix of resignations, shareholder dissent, and new appointments signals an ongoing 'Darwinian' reassessment of strategy and pipeline viability by institutional investors.

  • Capital Allocation as a Core Board Priority

    The filings show increasing emphasis on capital allocation decisions. IAC caps Diller's power, Primoris does a $50M buyback while slashing guidance (signaling long-term confidence), and MARA dilutes for a strategic pivot. Boards are increasingly judged on their capital allocation decisions, beyond just operational metrics.

Watch List (8)

  • The company stated the majority of renewables cost overruns will hit Q2 2026 results. Earnings call will be a critical event to assess if the guidance revision is one-time or structural. Management credibility is fully at stake.

  • Watch concentrated institutional selling (or buying) after the 40.8% withheld vote on a director. The shareholder base composition is a leading indicator of whether the governance shake-up will force management action.

  • The search for a new CFO is ongoing. The caliber and background of the candidate (e.g., a consumer tech expert vs. a restructuring specialist) will signal the board's strategic direction for the next phase.

  • Domino's Pizza / Leadership Transition
    👁

    (Oct 1, 2026) Joe Jordan takes over as CEO. Watch for any early signals of strategy shifts (e.g., expansion into new geographies, new menu innovations) in the first few quarterly earnings calls under the new leadership.

  • The company has begun a search for a new CMO. The quality of the hire will be a critical de-risking event for the pipeline. A poorly received candidate could kill the stock.

  • Inna Martin's employment/consultancy ends on Sept 10, 2026. The company's ability to gain regulatory traction or secure a partnership deal before this date will be key. The conflict indicates a high probability of a material corporate event.

  • With the Diller voting power capped, IAC becomes a more conventional governance structure. Watch for any activist investor (e.g., an Starboard Value) who previously stayed away due to Diller's power to now take a position.

  • The 20.6% vote against the equity plan is a shot across the bow. The company's next major announcement (trial data, partnership) will be heavily scrutinized for its economic terms, as dilution concerns are clearly top of mind for shareholders.

Filing Analyses (50)
SMITH A O CORP 8-K neutral materiality 5/10

22-06-2026

A. O. Smith Corporation announced that Executive Chairman Kevin Wheeler will retire effective July 1, 2026, and President & CEO Stephen Shafer has been elected by the board to assume the role of chairman upon Wheeler's retirement. Wheeler will remain on the board as a member. The combined chairman-CEO role is intended to strengthen alignment across strategy, operations, and long-term value creation.

  • · Wheeler joined A. O. Smith in 1994 as a regional sales manager and held various senior roles before becoming president and CEO in 2018 and chairman in 2020.
  • · Shafer joined A. O. Smith in 2024 as president and chief operating officer and was named president and CEO in July 2025.
  • · Shafer becomes the 11th CEO in company history to assume the role of chairman.
  • · Before A. O. Smith, Shafer held roles at 3M Company, McKinsey & Co., and Ford Motor Company.
  • · Shafer serves on the boards of the Air Conditioning, Heating, and Refrigeration Institute, the Metropolitan Milwaukee Association of Commerce, and the Executive Advisory Board for WorkBoard Inc.
ALIGN TECHNOLOGY INC 8-K neutral materiality 5/10

22-06-2026

Analysis unavailable

Panamera Holdings Corp 8-K neutral materiality 5/10

22-06-2026

Panamera Holdings Corporation announced the election of Blair Aiken as President, interim CEO, and Chairman of the Board, effective June 15, 2026, replacing T. Benjamin (Ben) Jennings as Chairman. The change is intended to drive the company's strategic combination with Rain Cage Carbon, Inc. No financial figures or performance metrics were disclosed in this filing.

  • · Blair Aiken was elected by the Board of Directors effective June 15, 2026.
  • · T. Benjamin (Ben) Jennings ceased serving as Chairman effective June 15, 2026.
  • · The filing was signed by Douglas Baker, CFO and Director, on June 22, 2026.
HF Foods Group Inc. 8-K positive materiality 5/10

22-06-2026

HF Foods Group Inc. appointed Taylor S. Brown, Esq. as an independent director to its Board, effective June 19, 2026, expanding the Board from four to five members. Mr. Brown brings over 12 years of experience in legal, acquisitions, and operational strategy, including managing a budget exceeding $100 million and leading a 21-region field organization with over 1,000 staffers. The appointment is intended to support the company's operational priorities and growth opportunities, though no committee assignments have been made yet.

  • · Mr. Brown has not been appointed to any Board committees at this time.
  • · He will be compensated on the same basis as other independent directors, as described in the company's Form 8-K filed June 28, 2024.
  • · Mr. Brown received his Juris Doctor from Mercer University, Walter F. George School of Law, and his Bachelor of Arts in Political Science from the University of Georgia.
  • · The appointment was effective June 19, 2026, and the filing was made on June 22, 2026.
SENTIENT BRANDS HOLDINGS INC. 8-K neutral materiality 5/10

22-06-2026

Sentient Brands Holdings Inc. announced the resignation of Dionne Pendleton as Director, Corporate Secretary, and Treasurer effective June 16, 2026, with no disagreement with the company. The Board appointed Derek Wyman as Director and Treasurer, and Serge Knazev as Director and Corporate Secretary, filling the vacancies. No material compensation arrangements have been finalized for the new appointees, and the company expects to file an amendment within four business days after terms are determined.

  • · Dionne Pendleton's resignation was not due to any disagreement with the company on operations, policies, or practices.
  • · The Board expects to continue engaging Pendleton's services on Board committees in an advisory capacity.
  • · Derek Wyman has over two decades of leadership experience and currently serves as Regional Vice President, Northwest at Model 1 Commercial Vehicles since February 2024.
  • · Serge Knazev was previously appointed President and COO effective January 1, 2026, and acting principal executive officer effective May 1, 2026.
  • · No material compensation plan, contract, or arrangement has been entered into with Wyman or Knazev in connection with their appointments; terms are yet to be determined.
  • · The company will file an amendment to this 8-K within four business days after material terms of compensatory arrangements are determined.
SPX Technologies, Inc. 8-K neutral materiality 3/10

22-06-2026

SPX Technologies, Inc. announced that John W. Swann III, President of its Detection and Measurement Segment, will retire in January 2027. The company filed an 8-K on June 22, 2026, regarding this officer departure.

  • · John W. Swann III informed the company of his retirement decision on June 18, 2026.
  • · His retirement is effective January 2027.
  • · The filing was made under Item 5.02 (Departure of Directors or Certain Officers).
EyePoint Pharmaceuticals, Inc. 8-K mixed materiality 6/10

22-06-2026

EyePoint Pharmaceuticals held its 2026 Annual Meeting on June 18, 2026, where stockholders approved an amendment to the 2023 Long-Term Incentive Plan to increase authorized shares by 4,900,000, elected all seven director nominees, and ratified Deloitte & Touche as the independent auditor. However, the Plan Amendment faced significant opposition with 13,010,393 votes against (20.6% of votes cast), indicating notable shareholder dissent on equity dilution.

  • · All seven director nominees were elected with strong support (over 94% of votes cast for each), with Jay S. Duker receiving the highest 'For' votes at 62,424,283.
  • · The non-binding advisory vote on executive compensation passed with 60,563,563 For vs. 2,033,575 Against, indicating broad shareholder approval.
  • · Ratification of Deloitte & Touche as auditor was nearly unanimous with 70,608,563 For and only 86,031 Against.
  • · Broker non-votes totaled 7,997,570 on all director elections and the Plan Amendment, representing about 11.3% of shares present.
CITIZENS FINANCIAL SERVICES INC 8-K neutral materiality 5/10

22-06-2026

Citizens Financial Services Inc (CZFS) appointed John D. Behm to its Board of Directors on June 16, 2026, and amended its Supplemental Executive Retirement Plan (SERP) to provide a 10.0% benefit for CFO Stephen J. Guillaume. The Board also finalized 2025 annual incentive bonuses for named executive officers, with CEO Randall E. Black receiving $590,601 in cash and total compensation of $1,803,244, while the median employee compensation was $48,896, resulting in a CEO pay ratio of 36.9:1. No negative or flat performance metrics were disclosed in this filing.

  • · John D. Behm serves on the Bank's Credit Committee and Trust Investment Committee.
  • · Mr. Behm's committee assignments on the Company Board have not yet been determined.
  • · The SERP benefit for Mr. Guillaume is based on the highest average annual cash compensation during any three non-consecutive completed calendar years in the ten years preceding termination.
  • · The Fourth Amendment replaced Appendix A and Appendix B of the SERP.
  • · The CEO pay ratio disclosure was omitted from the Proxy Statement because the CEO's bonus had not been determined at that time.
  • · The median employee was determined as of December 31, 2025, considering all employees (full-time, part-time, seasonal).
JUPITER NEUROSCIENCES, INC. 8-K neutral materiality 3/10

22-06-2026

On June 17, 2026, Allison W. Brady resigned from the Board of Directors of Jupiter Neurosciences, Inc., effective immediately, also stepping down from the Audit and Compensation Committees. Her resignation was not due to any disagreement with the company. The Board seat will remain vacant until the annual meeting on July 22, 2026.

  • · Ms. Brady also resigned from the Audit Committee and Compensation Committee.
  • · The Board seat will remain vacant until the annual meeting on July 22, 2026.
  • · The resignation was not due to any disagreement with the company's operations, policies, or practices.
AGILYSYS INC 8-K neutral materiality 6/10

22-06-2026

Agilysys, Inc. entered into a new employment agreement with CEO Ramesh Srinivasan on June 18, 2026, extending his role for a three-year initial term with automatic one-year renewals. The agreement maintains his base salary at $600,000 per year and includes a grant of 78,269 RSUs valued at $6.8M, split equally between time-based and performance-based vesting with stock price targets of $105, $120, and $135 per share. While the agreement provides retention stability, the performance hurdles represent ambitious growth targets from current levels, and the compensation structure includes significant equity dilution potential.

  • · The employment agreement includes severance of two years' base salary plus two times target bonus if terminated without cause or for good reason.
  • · In a change-of-control scenario within 24 months, severance increases to two times base salary plus target bonus, plus full release of post-closing equity restrictions.
  • · Non-competition and non-solicitation obligations extend for 24 months post-employment.
  • · The performance-based RSUs have three tranches with stock price targets of $105, $120, and $135 per share, all requiring continued employment through the second anniversary.
  • · If performance metrics are achieved before the second anniversary, 67% of the applicable tranche vests on that date, with the remainder vesting quarterly.
Revium Rx. 8-K neutral materiality 7/10

22-06-2026

On June 16, 2026, Inna Martin resigned as Director, COO, and President of Revium Rx. due to differences with the Company, effective immediately. She entered into a Separation Agreement extending the exercise period for vested stock options covering up to 2,440,000 shares to September 30, 2028, with her employment and consultancy ending on September 10, 2026. No financial metrics or period-over-period comparisons are provided in this filing.

  • · Ms. Martin did not hold any Board committee positions at the time of resignation.
  • · The Separation Agreement was between Ms. Martin and Revium Rx Ltd., a subsidiary of Revium Rx.
  • · The Company is an emerging growth company and has not elected the extended transition period for complying with new financial accounting standards.
JOHNSON OUTDOORS INC 8-K neutral materiality 5/10

22-06-2026

Johnson Outdoors Inc. appointed Asad Rahman as Vice President and CFO effective June 30, 2026, succeeding David W. Johnson who is retiring. Mr. Rahman will receive a $200,000 restricted stock award vesting in two years. Mr. Johnson will remain an employee through fiscal year end to assist with transition.

  • · Mr. Rahman has over 25 years of finance and accounting experience.
  • · He most recently served as Vice President – Finance, Supply Chain, Procurement and R&D at Mars since July 2023.
  • · From January 2022 to July 2023, he was CFO of Kellanova’s Away From Home Business Unit.
  • · He previously worked at S. C. Johnson & Son from 2005 to 2021, last as Senior Director overseeing North America FP&A and Sales.
  • · The restricted stock award vests on June 30, 2028.
  • · David W. Johnson will remain an employee until October 2, 2026 to assist transition.
AXT INC 8-K positive materiality 6/10

22-06-2026

AXT, Inc. announced the appointment of Tracy Liu to its Board of Directors, effective June 17, 2026, expanding the board from four to five members. Liu brings over 30 years of business advisory, tax, and accounting experience, including work with Big Four firms and extensive cross-border expertise in China and the U.S. The company is pursuing an aggressive capacity expansion strategy to meet surging demand for indium phosphide wafers driven by AI optical data transmission needs.

  • · Tracy Liu currently serves as an independent director and Chair of the Audit Committee of ACM Research, Inc. (Nasdaq: ACMR).
  • · Liu holds a master’s degree in accounting with a specialization in taxation and a bachelor’s degree in computer science; she is a CPA and AICPA member.
  • · AXT has partial ownership in over ten companies in China producing raw materials for its manufacturing process.
  • · The company's end markets include AI/data center connectivity, 5G infrastructure, passive optical networks, LED lighting, lasers, sensors, power amplifiers for wireless devices, and satellite solar cells.
TaskUs, Inc. 8-K neutral materiality 5/10

22-06-2026

TaskUs, Inc. appointed Rishabh Khemka as Chief Financial Officer, effective June 19, 2026, bringing over 20 years of financial leadership from Encora and Wipro. Trent Thrash, who served as Interim CFO since March 2026, will return to his role as SVP of Corporate Development, Investor Relations and Treasury, reporting to Khemka. The filing does not include any financial results or performance metrics, so no period-over-period comparisons are available.

  • · Rishabh Khemka most recently served as CFO at Encora, a digital engineering services firm backed by Advent International and Warburg Pincus, where he led financial integration after its acquisition by Coforge Limited.
  • · Khemka spent over 18 years at Wipro, last serving as CFO of its Americas business.
  • · Trent Thrash served as Interim CFO from March 2026 until Khemka's appointment.
Huron Consulting Group Inc. 8-K neutral materiality 3/10

22-06-2026

Huron Consulting Group Inc. elected Shoshana M. Vernick as a director effective June 19, 2026, to serve until the 2027 Annual Meeting. Ms. Vernick, co-founder and managing partner of Avathon Capital, brings expertise in education and knowledge services private equity. She will receive standard non-employee director compensation, including a prorated annual cash retainer of $80,000 and a prorated restricted stock grant valued at $90,000 (half of the annual $180,000 grant due to joining within six months of the annual meeting).

  • · Ms. Vernick has been appointed to the Compensation Committee, Finance and Capital Allocation Committee, and Technology and Information Security Committee.
  • · She will stand for re-election at the 2027 Annual Meeting.
  • · Ms. Vernick serves as Vice Chair of the Illinois Venture Capital Association (IVCA) and is a founding Board member of the IVCA Foundation.
  • · There are no arrangements or understandings between Ms. Vernick and any other persons regarding her election as a director, and she has no material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
NVE CORP /NEW/ 8-K neutral materiality 6/10

22-06-2026

NVE Corporation announced CEO Daniel A. Baker will retire effective August 6, 2026, with Peter G. Eames appointed as his successor. The Board will expand from five to seven directors, adding Carolyn W. Valentine as a new nominee. The filing does not include any financial results or performance metrics.

  • · Daniel A. Baker joined NVE in 2001 and led the company's transition from contract research to spintronics products.
  • · Peter G. Eames has been Vice President of Advanced Technology since 2016 and an NVE employee since 2003.
  • · Carolyn W. Valentine has been President of Grason-Stadler since October 2023.
  • · The CEO change is effective at the Annual Shareholders' meeting on August 6, 2026.
  • · Subject to shareholder approval, Dr. Baker will remain as Chairman, and Terrence W. Glarner will remain on the Board.
IAC Inc. 8-K neutral materiality 7/10

22-06-2026

IAC Inc. entered into a Voting Agreement with Barry Diller, Alexander von Furstenberg, and Diane von Furstenberg (the Diller Parties) on June 22, 2026. The agreement requires the Diller Parties to vote their Excess Voting Securities (shares above a 48.5% voting power threshold) in proportion to the vote of other stockholders, effectively capping the Diller Group's voting influence. The agreement also restricts the Diller Parties from initiating stockholder action by written consent without board approval and terminates automatically if the Diller Group's voting power falls below 30% or upon a Change of Control.

  • · The Diller Parties collectively own 889,947 shares of Common Stock and 5,789,499 shares of Class B Common Stock as of the agreement date.
  • · The agreement automatically terminates if the Diller Group's beneficial ownership falls below 30% of total voting power or upon a Change of Control.
  • · The Diller Parties are prohibited from initiating or participating in stockholder action by written consent unless directed by an Independent Committee of the Board.
  • · The agreement is governed by Delaware law and includes a jury trial waiver.
  • · The Diller Parties must use commercially reasonable efforts to ensure any transferee of shares joins the agreement.
BridgeBio Oncology Therapeutics, Inc. 8-K mixed materiality 5/10

22-06-2026

On June 16, 2026, BridgeBio Oncology Therapeutics held its Annual Meeting, where stockholders elected two Class I directors (Peter Lebowitz and Frank P. McCormick) and ratified Deloitte & Touche as independent auditor for FY2026. Director Michelle Doig resigned upon completion of her term, with no disagreement with the company. While director Lebowitz received overwhelming support (31,822,504 votes for), McCormick faced significant opposition with 6,171,757 votes withheld, representing about 19.4% of votes cast.

  • · The company is an emerging growth company as defined under SEC rules.
  • · Michelle Doig's resignation was effective June 16, 2026, upon completion of her term as a Class I director, and was not due to any disagreement with the company.
  • · There were 13,805,126 no votes on both proposals, representing approximately 28.6% of shares present or represented by proxy.
  • · Ratification of Deloitte & Touche was nearly unanimous with only 3,440 votes against and zero abstentions.
DOMINOS PIZZA INC 8-K positive materiality 8/10

22-06-2026

Domino's Pizza Inc. announced a CEO succession plan: COO Joe Jordan will become CEO effective October 1, 2026, while current CEO Russell Weiner will transition to Executive Chairman after the 2027 annual meeting. Executive Chairman David Brandon will retire from the board in 2027 after 28 years of service. The leadership changes reflect a multi-year succession plan, with Weiner's tenure including net store growth of over 3,200 locations, nearly $3 billion in global retail sales growth, and close to a 30% increase in operating income.

  • · Joe Jordan will join the Board of Directors on October 1, 2026.
  • · Russell Weiner will serve as Executive Chairman Designate from October 1, 2026 until the 2027 annual shareholder meeting, then become Executive Chairman.
  • · David Brandon served as CEO from 1999 to 2010 and as Chairman since 1999.
  • · Domino's had more than 22,300 stores in over 90 markets as of the filing date.
  • · Franchisees owned 99% of Domino's stores as of Q1 2026.
  • · Over 85% of U.S. retail sales in 2025 were generated via digital channels.
Oric Pharmaceuticals, Inc. 8-K mixed materiality 7/10

22-06-2026

ORIC Pharmaceuticals held its 2026 annual meeting on June 18, 2026, with 91.36% of outstanding shares represented. Stockholders approved the amended 2020 Equity Incentive Plan (removing the annual evergreen limit, reducing the annual increase to 4%, and capping incentive stock options at 10,000,000 shares) and elected all director nominees. However, Proposal 3 (equity plan) saw significant opposition, with approximately 27.3 million votes against and only 61.2 million for.

  • · Stockholders elected Jacob M. Chacko, M.D. with 89,298,150 votes for (vs. 408,106 withheld) and Mardi C. Dier with 82,007,899 votes for (vs. 7,698,357 withheld).
  • · Proposal 2 (ratification of KPMG as auditor) passed overwhelmingly: 94,536,096 for, 34,641 against, 544 abstain, no broker non-votes.
  • · Proposal 4 (advisory vote on executive compensation) passed with 88,453,809 for, 1,250,074 against, 2,373 abstain.
  • · Proposal 5 (frequency of future advisory votes) approved 'every one year' with 89,392,979 votes for one year vs. only 6,986 for two years and 294,916 for three years; next such vote no later than 2032 annual meeting.
  • · The amended 2020 Equity Incentive Plan also eliminated the administrator's ability to implement a program for surrendering/cancelling awards, transferring awards to third parties, or reducing exercise prices.
STAAR SURGICAL CO 8-K mixed materiality 7/10

22-06-2026

STAAR Surgical Company held its 2026 Annual Meeting on June 18, 2026, where shareholders approved an amendment to the Omnibus Equity Incentive Plan to increase authorized shares by 3.9 million. All seven director nominees were elected, and the appointment of BDO USA as auditor was ratified. However, the non-binding advisory vote on executive compensation received 1.45 million against votes (3.5% of votes cast), indicating some shareholder dissent.

  • · Shareholders approved the equity plan amendment with 40.2M for, 975K against, and 67.9K abstentions.
  • · The non-binding advisory vote on executive compensation (Proposal 4) had 39.7M for, 1.45M against, and 82.8K abstentions.
  • · All seven director nominees received over 40 million votes each, with the lowest being 40.5M for Louis E. Silverman.
  • · BDO USA was ratified as auditor with 43.4M for, 237K against, and 10K abstentions (no broker non-votes).
VALHI INC /DE/ 8-K neutral materiality 2/10

22-06-2026

Mary A. Tidlund notified Valhi, Inc. on June 17, 2026 of her resignation as a director, effective June 30, 2026. The resignation did not result from any disagreement with the company. No financial figures or period-over-period data are provided in this filing.

TD SYNNEX CORP 8-K positive materiality 5/10

22-06-2026

TD SYNNEX appointed Douglas Britt to its Board of Directors, effective June 17, 2026, increasing the board size from ten to eleven members. Britt, a seasoned technology executive with over 30 years of experience, will serve on the Audit and Technology Committees. The appointment strengthens governance and strategic oversight, particularly in hyperscale digital infrastructure, but no negative or flat performance metrics were disclosed in this filing.

  • · Britt currently serves as Executive Chairman of Boyd, having previously led the sale of Boyd Thermal business to Eaton Corporation in 2026.
  • · Britt currently serves on the boards of Helios Technologies and Benchmark Electronics.
  • · Britt holds a Bachelor of Science in Business Administration from California State University, Chico, and completed executive education programs at the University of London.
  • · TD SYNNEX is a Fortune 100 company with a comprehensive edge-to-cloud portfolio spanning cybersecurity, analytics, artificial intelligence, mobility, and Everything-as-a-Service.
indie Semiconductor, Inc. 8-K neutral materiality 6/10

22-06-2026

indie Semiconductor announced the resignation of co-founder Dr. Ichiro Aoki as President and board member effective June 29, 2026, transitioning him to a Technical Advisor role. Thomas Schiller, former CFO and Strategic Advisor, has been appointed to the Board of Directors to support strategic execution as the company expands into adjacent physical AI markets including robotics and humanoids.

  • · Dr. Aoki has been with indie since its inception as a co-founder and oversaw engineering plan execution.
  • · Thomas Schiller previously served as indie's CFO and Executive Vice President of Strategy until June 2024, leading financing, reporting, investor relations, treasury, tax, and M&A.
  • · Schiller has been a Strategic Advisor to indie since November 2024, providing guidance in strategic planning and M&A.
  • · Schiller played an instrumental role in steering indie's 2021 IPO.
  • · Schiller holds an MBA from USC specializing in Entrepreneurship and Finance, and a BA from UC Irvine; he also completed executive education at UCLA and MIT.
Dyne Therapeutics, Inc. 8-K neutral materiality 3/10

22-06-2026

Dyne Therapeutics elected Barry E. Greene as a Class I independent director on June 22, 2026, to serve until the 2027 Annual Meeting. He received an option to purchase 57,463 shares at $20.87 per share, vesting over three years, and annual cash compensation of $45,000. No other material changes or negative developments were disclosed.

  • · Mr. Greene has not been appointed to any Board committees.
  • · The option vests in equal monthly installments over three years, with full acceleration upon a change in control.
  • · Mr. Greene will also receive annual equity grants under the non-employee director compensation program and reimbursement for travel expenses.
  • · No arrangements or understandings exist between Mr. Greene and any other person regarding his election.
  • · No family relationships with directors or executive officers, and no related-party transactions requiring disclosure.
COMFORT SYSTEMS USA INC 8-K neutral materiality 5/10

22-06-2026

Comfort Systems USA announced leadership transitions effective July 1, 2026, including the appointment of Craig Sasser as Chief Operating Officer and Briston Blair as Chief Strategy & Innovation Officer. Trent T. McKenna will continue as President. The changes reflect internal promotions aimed at long-term growth, but no financial or operational performance data was disclosed in this filing.

  • · Craig Sasser has been with Comfort Systems since September 2018, previously serving as Regional Vice President for the North and Atlantic regions.
  • · Briston Blair has served as Senior Vice President – Innovation & Strategy since January 2022, and previously held roles including Regional Vice President and Senior Growth Strategy & Corporate Development Advisor.
  • · No financial metrics, revenue changes, or performance comparisons were provided in this filing.
COMPX INTERNATIONAL INC 8-K neutral materiality 3/10

22-06-2026

Mary A. Tidlund notified CompX International Inc. of her resignation as a director, effective June 30, 2026. The resignation did not result from any disagreement with the company. No financial impact or other operational changes were disclosed.

  • · Resignation effective date: June 30, 2026
  • · No disagreement with the company was cited as reason for departure
  • · Filing date: June 22, 2026
FIREFLY NEUROSCIENCE, INC. 8-K neutral materiality 3/10

22-06-2026

Firefly Neuroscience, Inc. (AIFF) filed an 8-K on June 22, 2026, reporting that Gil Issachar, formerly Chief Technology Officer, transitioned to Head of AI and Neuroscience effective June 18, 2026, via an employment agreement with Deel Innovation Ltd. As a result, Issachar is no longer classified as a Section 16 officer or executive officer. No financial figures or performance metrics were disclosed in this filing.

  • · Issachar's employment agreement includes a Determined Salary of ILS 50,000 per month (Base Salary ILS 48,000 + Global Overtime Consideration ILS 2,000).
  • · A total outstanding bonus of ILS 131,250 is payable in 20 equal monthly installments of ILS 6,562.5 each.
  • · The role is full-time (minimum 42 hours per week) with a remote work location in Israel.
  • · Annual vacation leave is 22 days per year with carryover allowed.
  • · Notice period is 30 days from start date.
  • · The agreement is not subject to a probationary period.
  • · Company contributes 7.5% of Determined Salary to an Education Fund (Keren Hishtalmut), with employee contributing 2.5%.
HeartBeam, Inc. 8-K neutral materiality 5/10

22-06-2026

HeartBeam, Inc. granted its President and Founder Branislav Vajdic a performance-based restricted stock unit award of 2,800,000 RSUs and a transaction bonus agreement tied to market capitalization thresholds. The PRSU vests based on operational milestones and service conditions, while the transaction bonus pays up to 2% of Aggregate Price Paid if market cap exceeds certain undisclosed thresholds. No financial results or period comparisons are included.

  • · The PRSU award is under the 2022 Equity Incentive Plan.
  • · Performance conditions relate to operational, software, product-development and clinical study milestones within one year of grant.
  • · Service-based vesting occurs one-third on each of first three anniversaries, with accelerated vesting upon Change in Control.
  • · Transaction bonus is 1% of Aggregate Price Paid if market cap is at least [***], plus additional 0.5% for each of two higher thresholds.
  • · No bonus payable if market cap is below the minimum threshold.
  • · Bonus is paid in same form as stockholder consideration, but Board may elect cash.
  • · Payment within 30 days after closing; post-closing payments subject to same terms as stockholders, forfeited if not paid by 5th anniversary.
  • · Agreement terminates upon completion of payments, first Qualifying Change in Control with $0 bonus, termination of employment before Change in Control, or Expiration Date.
Five9, Inc. 8-K neutral materiality 4/10

22-06-2026

Five9, Inc. announced the planned departure of Panos Kozanian, Executive Vice President of Product Engineering, effective June 29, 2026, with a transition period through at least September 4, 2026. The company will announce a new Chief Technology Officer by the end of Q2 2026. Mr. Kozanian will remain eligible for severance benefits under the Key Employee Severance Plan unless terminated for cause.

  • · Transition effective June 29, 2026; Mr. Kozanian expected to serve through at least September 4, 2026.
  • · New CTO to be announced by end of Q2 2026.
  • · Mr. Kozanian is a Tier 3 participant in the Key Employee Severance Plan.
ARVINAS, INC. 8-K neutral materiality 4/10

22-06-2026

Arvinas, Inc. announced the departure of Chief Medical Officer Noah Berkowitz, M.D., Ph.D., effective July 3, 2026, to pursue other opportunities. The company has begun a search for a replacement. Dr. Berkowitz will receive severance benefits including nine months of base salary and health coverage, plus accelerated vesting of certain RSUs that would have vested on or before May 9, 2027; all other unvested RSUs will be forfeited.

  • · Departure effective date: July 3, 2026
  • · Separation agreement includes release of claims, continued compliance with proprietary information and assignment agreement, confidentiality, cooperation, and non-disparagement obligations
  • · Accelerated vesting applies only to RSUs that would vest on or before May 9, 2027; all other unvested RSUs are forfeited
  • · Acceleration of vesting is subject to taxation and applicable withholdings
  • · The full separation agreement will be filed with the Form 10-Q for the quarter ending June 30, 2026
BEST BUY CO INC 8-K mixed materiality 6/10

22-06-2026

Best Buy announced that CFO Matt Bilunas will step down on July 31, 2026, after 20 years with the company, including seven as CFO. The company has engaged an external search firm to find a successor with previous CFO experience, while current CEO Corie Barry—herself a former CFO—will provide financial oversight during the transition if needed. Bilunas leaves as Best Buy generated $41.7 billion in revenue in fiscal 2026 and operates over 1,000 stores with more than 80,000 employees, and incoming CEO Jason Bonfig takes over on November 1, 2026.

  • · Bilunas joined Best Buy in July 2006 as a Territory Finance Director and held roles including SVP of Enterprise Finance before becoming CFO in 2019.
  • · Bilunas was responsible for finance, enterprise strategy, procurement, financial services, real estate, and omnichannel operations.
  • · Best Buy is the world's largest specialty consumer electronics retailer.
PagerDuty, Inc. 8-K positive materiality 6/10

22-06-2026

PagerDuty, Inc. (NYSE: PD) announced the appointment of Eric Prengel as Chief Financial Officer, effective June 22, 2026. He succeeds Howard Wilson, who is retiring before the end of the second quarter of fiscal 2027 (July 31, 2026). Prengel brings over 20 years of leadership experience from Elastic, JPMorgan, and Deutsche Bank, and will oversee finance, business operations, corporate strategy, development, and investor relations. The filing highlights PagerDuty's AI-first operations management platform, which serves approximately two-thirds of the Fortune 100 and nearly half of the Fortune 500.

  • · Eric Prengel earned his bachelor's degree from the University of Pennsylvania in economics.
  • · Howard Wilson is retiring before the end of Q2 FY2027 (July 31, 2026).
  • · PagerDuty serves approximately two-thirds of the Fortune 100 and nearly half of the Fortune 500.
Primoris Services Corp 8-K mixed materiality 9/10

22-06-2026

Primoris Services Corporation (PRIM) announced a significant downward revision to its full-year 2026 guidance, primarily due to additional cost overruns and delays on six Renewables projects, with net income expected to be $71M-$101M (down from $223M-$234M) and Adjusted EBITDA of $275M-$325M (down from $480M-$500M). The company also reported the departure of COO Jeremy Kinch, with CEO Koti Vadlamudi assuming most COO responsibilities. Despite these headwinds, Primoris secured approximately $2.0 billion in new Energy segment awards during Q2 2026 and repurchased $50 million of common stock, reflecting confidence in long-term growth.

  • · The company expects the majority of the Renewables cost overruns to be reflected in Q2 2026 results.
  • · Adjusted EPS guidance was lowered to $2.05-$2.60 per share from $4.80-$5.00 per share.
  • · Diluted EPS guidance was lowered to $1.30-$1.85 per share from $4.05-$4.25 per share.
  • · The company repurchased shares at an average price of approximately $111.29 per share during Q2 2026.
  • · The share repurchase program expires on April 30, 2028, with approximately $100 million remaining.
  • · Management plans to participate in the 2026 J.P. Morgan Natural Resources Conference on June 24, 2026, and the CJS Securities 26th Annual 'New Ideas' Summer Conference on July 9, 2026.
CENTENE CORP 8-K positive materiality 5/10

22-06-2026

Centene Corporation announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler brings over 30 years of leadership experience from JPMorgan Chase, TSG Capital Partners, Allen & Company, and Morgan Stanley, and will serve on the Audit and Compensation and Talent Committees. The appointment strengthens the board's governance and operational expertise as the company continues its strategic evolution.

  • · Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee.
  • · She currently serves on the boards of Cencora, Inc., and Guardian Life, and previously served on the board of Alleghany Corporation until its acquisition in 2022.
  • · Ms. Tyler holds an MBA from Harvard Business School and a BA from Yale University.
  • · Centene serves more than 1 in 15 individuals across the nation.
Guardian Pharmacy Services, Inc. 8-K neutral materiality 4/10

22-06-2026

Guardian Pharmacy Services, Inc. (GRDN) announced leadership transitions effective July 1, 2026, including the retirement of Executive Vice President Kendall Forbes, appointment of David Morris as Chief Operating Officer (formerly CFO), and appointment of Will Mudd as Chief Financial Officer (formerly SVP, Finance). The changes reflect the company’s focus on internal succession planning and leadership depth as it continues to grow. No specific financial performance or negative metrics were disclosed in this filing.

  • · Kendall Forbes served as EVP of Sales & Operations since 2004 and after 22 years with the company, effective retirement date is July 1, 2026.
  • · Will Mudd joined Guardian in 2012 as SVP, Finance, overseeing financial accounting and reporting, revenue cycle management, and human resources; prior to Guardian, spent ~10 years in audit at Grant Thornton.
  • · No financial results or performance metrics were disclosed in this filing.
OneMain Holdings, Inc. 8-K mixed materiality 6/10

22-06-2026

OneMain Holdings held its 2026 Annual Meeting on June 16, 2026, where stockholders approved the 2026 Omnibus Incentive Plan, elected Phyllis R. Caldwell and Roy A. Guthrie as Class I directors, and ratified PricewaterhouseCoopers LLP as auditor for fiscal 2026. The advisory Say on Pay proposal passed with strong support (89.1M for vs 2.6M against), and the Board determined future advisory votes will be held annually. However, the Director Election Proposal showed notable opposition, with Phyllis R. Caldwell receiving 12.5M against votes (13.6% of votes cast excluding broker non-votes), indicating significant shareholder dissent.

  • · The 2026 Omnibus Incentive Plan was approved with 88.5M for, 3.2M against, and 182,913 abstentions.
  • · Auditor Ratification Proposal passed with 100.9M for, 1.9M against, and 120,995 abstentions (no broker non-votes).
  • · Say on Pay Frequency Proposal: 86.8M voted for 1 Year, 82,793 for 2 Years, 4.8M for 3 Years, and 226,098 abstained.
  • · Broker non-votes totaled 10,992,128 on all proposals except the Auditor Ratification Proposal (which had none).
  • · The Board determined future advisory Say on Pay votes will be held annually.
EMPIRE PETROLEUM CORP 8-K neutral materiality 5/10

22-06-2026

Empire Petroleum Corp held its Annual Meeting on June 17, 2026, with 76.44% of outstanding shares represented. Stockholders approved the 2026 Stock and Incentive Compensation Plan (reserving 1,200,000 shares) and elected three directors, while also ratifying Grant Thornton LLP as the independent auditor for 2026. The advisory vote on executive compensation passed with strong support (97.7% of votes cast), but a notable 9,239,010 broker non-votes were recorded on all director and compensation proposals, indicating some shareholder abstention.

  • · The 2026 Plan replaces the 2024 Plan; no further awards will be made under the 2024 Plan.
  • · All employees, consultants, and non-employee directors are eligible for awards under the 2026 Plan.
  • · Awards may include incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, cash-based awards, and other stock-based awards.
  • · Proposal Four (ratification of Grant Thornton) received 30,104,778 votes for, 2,163 against, and 301,907 abstentions, with zero broker non-votes.
  • · The three directors elected (Morrisett, Lewis, Vann) each received over 20 million votes for, with less than 1 million withheld each.
CytomX Therapeutics, Inc. 8-K neutral materiality 5/10

22-06-2026

CytomX Therapeutics, Inc. filed an 8-K on June 22, 2026, announcing a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, which increases the authorized common stock from an unspecified prior amount to 600,000,000 shares (par value $0.00001 per share) and authorized preferred stock remains at 10,000,000 shares. The amendment was approved by the Board of Directors and stockholders, and the filing also covers director/officer changes (Items 5.02, 5.03, 5.07) but no specific details on those changes are provided in the exhibit.

  • · The Certificate of Amendment was filed with the Delaware Secretary of State on June 22, 2026.
  • · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
  • · The original Certificate of Incorporation was filed on September 16, 2010, and the most recent restated certificate was filed on May 17, 2024.
  • · The filing includes Items 5.02 (Departure of Directors or Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 5.07 (Submission of Matters to a Vote of Security Holders), but no specific details on officer/director changes or voting results are provided in the exhibit.
MARA Holdings, Inc. 8-K mixed materiality 7/10

22-06-2026

MARA Holdings, Inc. held its 2026 annual meeting on June 18, 2026, where shareholders approved an amendment to the 2018 Equity Incentive Plan, increasing authorized shares by 18,000,000. Shareholders also ratified the appointment of PricewaterhouseCoopers as independent auditor and approved, on a non-binding advisory basis, executive compensation. Class III directors Vicki Mealer-Burke and Douglas Mellinger were elected, though both received significant broker non-votes and Mealer-Burke had a notable 40.8% withheld vote.

  • · The annual meeting was held on June 18, 2026, with a quorum of 213,399,096 shares.
  • · Vicki Mealer-Burke received 65,489,872 votes for and 45,085,559 votes withheld (40.8% withheld), while Douglas Mellinger received 100,494,708 votes for and 10,080,723 votes withheld (9.1% withheld).
  • · The ratification of PwC as auditor was approved with 208,334,659 votes for (97.6% of total shares voted), 4,190,775 against, and 873,662 abstentions.
  • · Advisory approval of NEO compensation received 64,973,538 votes for (59.0% of votes cast excluding broker non-votes), 44,975,240 against, and 626,653 abstentions.
  • · The 2018 Plan amendment was approved with 83,714,947 votes for (75.9% of votes cast excluding broker non-votes), 26,423,491 against, and 436,993 abstentions.
  • · No other matters were presented at the annual meeting.
Bunker Hill Mining Corp. 8-K neutral materiality 4/10

22-06-2026

Bunker Hill Mining Corp. announced the resignation of Mr. Mark Child from its Board of Directors, effective immediately. The company is advancing the restart of its historic Bunker Hill Mine in Idaho, with the 1,800tpd operation due to start in June 2026. The Board will evaluate its composition and determine whether to appoint a replacement director in due course.

  • · Mr. Child served as a director since earlier in 2026.
  • · The Bunker Hill Mine is located in northern Idaho's Coeur d'Alene mining district.
  • · The company is a U.S.-based exploration and development company.
FB Bancorp, Inc. /MD/ 8-K neutral materiality 5/10

22-06-2026

FB Bancorp, Inc. filed an 8-K with the SEC on June 22, 2026, disclosing a director/officer departure or election under Item 5.02. The filing was signed by Christopher S. Ferris, President and Chief Financial Officer, indicating a leadership change. However, the filing does not specify the nature of the departure/election, the departing or new officer/director, or any effective dates, leaving material details unclear.

  • · Filing type is 8-K, dated June 22, 2026, for the period ending June 30, 2026.
  • · Items reported: 5.02 (Director/Officer Departure/Election) and 9.01 (Financial Statements and Exhibits).
  • · Exhibit 104 is the Cover Page Interactive Data File (Inline XBRL).
  • · No financial statements or quantitative details were provided in this filing.
BITGO HOLDINGS, INC. 8-K neutral materiality 3/10

22-06-2026

BitGo Holdings, Inc. (BTGO) disclosed in an 8-K filing that Chief Compliance Officer Jeffrey Horowitz will retire effective June 19, 2026, with his decision not resulting from any disagreement with the company. The filing contains no financial data or period-over-period comparisons.

  • · Jeffrey Horowitz's retirement is effective June 19, 2026, one day after his notice on June 18, 2026.
  • · The filing confirms no disagreement with the company regarding operations, policies, or practices.
  • · BitGo's Class A Common Stock trades on the NYSE under ticker BTGO.
Hudson Pacific Properties, Inc. 8-K neutral materiality 4/10

22-06-2026

Hudson Pacific Properties, Inc. announced the resignation of Andrew Wattula, Chief Operating Officer, effective June 18, 2026. Mr. Wattula, who joined the company in 2017 and became COO in 2021, is leaving for reasons unrelated to any financial, accounting, or operational disagreements. His duties have been reassigned to existing executives while the company evaluates potential replacements.

  • · Andrew Wattula joined the company in 2017 and was appointed COO in 2021.
  • · His resignation is not related to any financial or accounting issues or disagreements with company operations, policies, or practices.
  • · Duties and responsibilities have been reassigned to existing executive officers and other management personnel.
  • · The company is considering potentially backfilling his role.
IMA Tech 8-K neutral materiality 9/10

22-06-2026

On June 17, 2026, Inderjit Mangat acquired 1,500,000 shares (57.47% voting control) of IMA Tech from Wang Hui for $300,000, triggering a change in control. Wang Hui resigned as Sole Director and all officer positions, and Ms. Mangat was appointed as Sole Director, President, CEO, Treasurer, and Secretary. The acquisition was funded with $75,000 cash and a $225,000 secured note payable in two installments due July 15 and August 15, 2026, with the Control Shares pledged as collateral.

  • · Inderjit Mangat, 65, holds a degree in Electrical Engineering from San Jose State University and worked as a UNIX Network Administrator for the U.S. Department of War for over 30 years with top security clearance.
  • · Since 2023, Ms. Mangat has owned and operated Amar Capital Corp., an Elk Grove, California-based real estate firm.
  • · The secured note is payable in two equal installments: $112,500 on July 15, 2026, and $112,500 on August 15, 2026.
  • · The Control Shares are pledged as security for the note in favor of Wang Hui.
  • · Total outstanding shares as of the filing date: 2,609,878.
Revolution Medicines, Inc. 8-K neutral materiality 5/10

22-06-2026

Revolution Medicines, Inc. disclosed the planned retirement of President of R&D Steve Kelsey, M.D., effective January 4, 2027, with a transition to senior advisor to the CEO starting July 1, 2026, and a potential board appointment upon retirement. The company also reported results from its June 18, 2026 annual meeting, where stockholders elected two Class III directors (Alexis Borisy and Mark A. Goldsmith), ratified PricewaterhouseCoopers as auditor, and approved executive compensation on a non-binding advisory basis. No financial results or period-over-period comparisons were provided in this filing.

  • · Dr. Kelsey will transition to senior advisor to the CEO from July 1, 2026, until his retirement on January 4, 2027.
  • · Upon retirement, Dr. Kelsey will be eligible for benefits under the company's retirement policy for equity awards.
  • · Board appointment for Dr. Kelsey is contemplated but subject to Board approval.
  • · Annual meeting voting results: Alexis Borisy received 127,181,172 votes for and 33,660,532 withheld; Mark A. Goldsmith received 157,681,628 votes for and 3,160,076 withheld.
  • · Ratification of PricewaterhouseCoopers: 181,309,783 for, 206,306 against, 139,256 abstentions.
  • · Advisory vote on executive compensation: 155,110,825 for, 5,554,146 against, 176,733 abstentions, with 20,813,641 broker non-votes.
  • · Record date for the annual meeting was April 23, 2026, with 212,592,561 shares outstanding and entitled to vote.
Polaris Inc. 8-K neutral materiality 4/10

22-06-2026

Polaris Inc. appointed Dustin J. Semach, President and CEO of Sealed Air Corporation, to its Board of Directors effective June 19, 2026. Semach brings extensive experience in finance, strategy, and operations from leadership roles at Sealed Air, TTEC Holdings, Rackspace Technology, DXC Technology, and IBM)Skip. He will serve on the Audit and Compensation Committees. No financial figures or period-over-period comparisons are included in this filing.

  • · Dustin Semach was appointed President and CEO of Sealed Air in February 2025 after joining as CFO in 2023.
  • · Semach will serve on the Board’s Audit Committee and Compensation Committee.
  • · Polaris is headquartered in Minnesota and serves customers in nearly 100 countries.
CACI INTERNATIONAL INC /DE/ 8-K neutral materiality 5/10

22-06-2026

CACI International Inc announced the appointment of Dr. Dave Young as Executive Vice President and Chief Operating Officer, effective June 22, 2026. Dr. Young brings extensive leadership experience from Lockheed Martin and CAES, including managing a $7 billion revenue business. The appointment aims to strengthen operational execution and support growth, though no financial impact or performance metrics were disclosed.

  • · Dr. Young holds a Ph.D. and Master of Science in Aerospace Engineering from Georgia Institute of Technology, and bachelor's degrees in Aeronautical Engineering and Physics from Clarkson University.
  • · CACI is a Fortune 500 company, listed on the Russell 1000 Index and S&P MidCap 400 Index.
  • · The filing includes forward-looking statements subject to risk factors in CACI's Annual Report on Form 10-K for fiscal year ended June 30, 2025.
LIFETIME BRANDS, INC 8-K neutral materiality 4/10

22-06-2026

Lifetime Brands, Inc. held its 2026 Annual Meeting on June 18, 2026, where stockholders elected directors, ratified Ernst & Young LLP as auditor for FY2026, approved 2025 executive compensation on a non-binding advisory basis, and approved an amendment to the 2000 Long-Term Incentive Plan. The Board also declared a quarterly cash dividend of $0.0425 per share payable August 14, 2026. No negative or flat performance metrics were disclosed in this filing.

  • · Stockholders ratified Ernst & Young LLP as independent auditor for the year ending December 31, 2026.
  • · On a non-binding advisory basis, stockholders approved 2025 compensation of named executive officers.
  • · Stockholders approved an amendment and restatement of the Amended and Restated 2000 Long-Term Incentive Plan.
  • · The dividend record date is July 31, 2026.
REINSURANCE GROUP OF AMERICA INC 8-K neutral materiality 6/10

22-06-2026

Reinsurance Group of America (RGA) announced Laura Cockrill as its new CFO, effective immediately, succeeding Axel André who departs on July 17, 2026. Cockrill brings over 25 years of experience at RGA, most recently as Chief Strategy Officer. The company reported $4.3 trillion of life reinsurance in force and total assets of $164.1 billion as of March 31, 2026.

  • · Laura Cockrill previously served as Chief Strategy Officer and Deputy CFO, and before that as CFO for the Americas region.
  • · Axel André will leave the company on July 17, 2026.
  • · Cockrill has held roles across business, capital, collateral, investments, treasury, and financial planning and analysis.
  • · RGA was founded in 1973.

Get daily alerts with 12 investment signals, 12 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Board Director Changes SEC Filings

🇺🇸 More from United States

View all →